Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

Briete Goorts*, Thiemo J. A. van Nijnatten, Linda de Munck, Martine Moossdorff, Esther M. Heuts, Maaike de Boer, Marc B. I. Lobbes, Marjolein L. Smidt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)83-91
Number of pages9
JournalBreast Cancer Research and Treatment
Volume163
Issue number1
DOIs
Publication statusPublished - May 2017

Keywords

  • Breast cancer
  • Pathological complete response
  • Neoadjuvant chemotherapy
  • Tumor size
  • Survival
  • RECTAL-CANCER
  • DOXORUBICIN
  • SURVIVAL
  • THERAPY
  • WATCH
  • WAIT

Cite this